Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rilan Bai
Observed names:
Bai Rilan,
R. Bai
Institution:
First Hospital of Jilin University
Observed institutions:
Guizhou University,
Jilin University,
First Hospital of Jilin University,
First Bethune Hospital of Jilin University
ORCID:
0000-0001-5502-8295
Observed ORCID:
0000-0001-5502-8295
OpenAlex ID:
A5021832583
Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors
2020
·
Rilan Bai
, Zheng Lv
, et al.
·
Biomarker Research
·
555
PDF
Mechanisms of Cancer Resistance to Immunotherapy
2020
·
Rilan Bai
, Naifei Chen
, et al.
·
Frontiers in Oncology
·
393
PDF
Mitochondrial immune regulation and anti-tumor immunotherapy strategies targeting mitochondria
2023
·
Rilan Bai
, Jiuwei Cui
·
Cancer Letters
·
89
Neoadjuvant and Adjuvant Immunotherapy: Opening New Horizons for Patients With Early-Stage Non-small Cell Lung Cancer
2020
·
Rilan Bai
, Lingyu Li
, et al.
·
Frontiers in Oncology
·
62
PDF
Development of Immunotherapy Strategies Targeting Tumor Microenvironment Is Fiercely Ongoing
2022
·
Rilan Bai
, Jiuwei Cui
·
Frontiers in Immunology
·
52
PDF
Analysis of characteristics and predictive factors of immune checkpoint inhibitor-related adverse events
2021
·
Rilan Bai
, Naifei Chen
, et al.
·
Cancer Biology and Medicine
·
52
Burgeoning Exploration of the Role of Natural Killer Cells in Anti-PD-1/PD-L1 Therapy
2022
·
Rilan Bai
, Jiuwei Cui
·
Frontiers in Immunology
·
35
PDF
Precision targeted therapy for EGFR mutation‐positive NSCLC : Dilemmas and coping strategies
2023
·
Ying Meng
, Rilan Bai
, et al.
·
Thoracic Cancer
·
27
PDF
Therapeutic strategies targeting metabolic characteristics of cancer cells
2023
·
Rilan Bai
, Ying Meng
, et al.
·
Critical Reviews in Oncology/Hematology
·
23
Correlation of Peripheral Blood Parameters and Immune-Related Adverse Events with the Efficacy of Immune Checkpoint Inhibitors
2021
·
Rilan Bai
, Lingyu Li
, et al.
·
Journal of Oncology
·
20
PDF
Single Nucleotide Polymorphisms in HOTAIR Are Related to Breast Cancer Risk and Prognosis in the Northeastern Chinese Population
2021
·
Zheng Lv
, Changgui Kou
, et al.
·
Frontiers in Oncology
·
19
PDF
Challenges of evaluating immunotherapy efficacy in solid tumors
2019
·
Rilan Bai
, Wenqian Li
, et al.
·
Chinese Journal of Cancer Research
·
19
PDF
Regulation of fatty acid synthase on tumor and progress in the development of related therapies
2024
·
Rilan Bai
, Jiuwei Cui
·
Chinese Medical Journal
·
16
ADAR1 Promotes Invasion and Migration and Inhibits Ferroptosis via the FAK/AKT Pathway in Colorectal Cancer
2024
·
Dongsheng He
, Chao Niu
, et al.
·
Molecular Carcinogenesis
·
15
PDF
Advances in novel molecular typing and precise treatment strategies for small cell lung cancer
2021
·
Rilan Bai
, Lingyu Li
, et al.
·
Chinese Journal of Cancer Research
·
13
PDF
[Advances in Combination Therapy of Immune Checkpoint Inhibitors for Lung Cancer].
2020
·
Hanfei Guo
, Rilan Bai
, et al.
·
PubMed Central
·
12
PDF
Precision Detection Technology: Equipping Precision Oncology with Wings
2020
·
Rilan Bai
, Zheng Lv
, et al.
·
Journal of Oncology
·
10
PDF
Cost‐effectiveness of icotinib versus whole‐brain irradiation with or without chemotherapy in EGFR‐mutant NSCLC patients with brain metastases
2020
·
Wenqian Li
, Rilan Bai
, et al.
·
Asia-Pacific Journal of Clinical Oncology
·
10
Potential new applications of immunotherapy for neuroendocrine neoplasms: immune landscape, current status and future perspectives
2022
·
Rilan Bai
, Wenqian Li
, et al.
·
Cancer Biology and Medicine
·
9
PDF
Novel Frontiers of Treatment for Advanced Gastric or Gastroesophageal Junction Cancer (GC/GEJC): Will Immunotherapy Be a Future Direction?
2020
·
Rilan Bai
, Naifei Chen
, et al.
·
Frontiers in Oncology
·
9
PDF
Immune status and combined immunotherapy progression in Kirsten rat sarcoma viral oncogene homolog (KRAS) mutant tumors
2024
·
Dongsheng He
, Rilan Bai
, et al.
·
Chinese Journal of Cancer Research
·
8
Therapeutic exploration of uncommon EGFR exon 20 insertion mutations in advanced non-small cell lung cancer: breaking through brambles and thorns
2021
·
Rilan Bai
, Xiao Chen
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
7
Epidermal growth factor receptor compound and concomitant mutations: advances in precision treatment strategies
2023
·
Wenqian Li
, Rilan Bai
, et al.
·
Chinese Medical Journal
·
5
Maintenance therapy with anlotinib after induction therapy with platinum-based chemotherapy for advanced non-small-cell lung cancer: A pooled analysis of 2 single-arm trials
2024
·
Yiqian Liu
, Liyun Miao
, et al.
·
Medicine
·
3
Targeted therapy combined with immunotherapy in patients with breast infiltrating ductal carcinoma with axillary lymph node metastasis of metaplastic SCC
2022
·
Rilan Bai
, Lin Jia
, et al.
·
Thoracic Cancer
·
2
PDF
Show more works
View as search
Works count:
37
Citation count:
1,469
H-index:
14
I10-index:
18
Year
Topic
Type